{"format":"alysly-page/1","url":"https://alysly.com/markets/stocks/galderma-group-ag/","json":"https://alysly.com/json/markets/stocks/galderma-group-ag/index.json","lang":"en-US","title":"Galderma Group N AG (GALD) Stock Price | CH1335392721 | News","description":"Galderma Group N AG (GALD). Health Care stock, Switzerland. Held in 25 ETFs (top 0.47% in SPFS). ISIN CH1335392721.","modified":"2026-11-02T00:00:00Z","alternates":[{"lang":"de-DE","url":"https://alysly.com/de/maerkte/aktien/galderma-group-ag/","json":"https://alysly.com/json/de/maerkte/aktien/galderma-group-ag/index.json"}],"about":"Machine-readable version of the page at url. It contains the text, tables and key figures published there, but not the interactive charts and tools.","breadcrumb":[{"name":"Markets","url":"https://alysly.com/markets/"},{"name":"Stocks","url":"https://alysly.com/markets/stocks/"},{"name":"Galderma Group N AG","url":"https://alysly.com/markets/stocks/galderma-group-ag/"}],"content":[{"type":"heading","level":1,"text":"Galderma Group N AG (GALD)"},{"type":"paragraph","text":"GALD · Health Care · Switzerland","links":[{"text":"Health Care","href":"https://alysly.com/markets/stocks/browse/?sector=Health%20Care"},{"text":"Switzerland","href":"https://alysly.com/markets/stocks/browse/?country=Switzerland"}]},{"type":"paragraph","text":"Galderma Group N AG (GALD) is a Swiss company in the Health Care sector. The stock has its largest weight in SPFS (MSCI World Health Care), at 0.47%. Anyone who holds an ETF containing Galderma Group N also has an indirect stake in the company."},{"type":"heading","level":2,"id":"data","text":"Data and Charts: Galderma Group N"},{"type":"heading","level":3,"text":"Key Data for Galderma Group N"},{"type":"facts","items":[{"label":"Held in","value":"25 ETFs"},{"label":"Highest weight","value":"0.47%"},{"label":"Indices","value":"10"},{"label":"Sector","value":"Health Care"},{"label":"Country","value":"Switzerland"},{"label":"ISIN","value":"CH1335392721"}]},{"type":"paragraph","text":"Data note 1","href":"#dn-1"},{"type":"heading","level":2,"id":"alysly","text":"Alysly Data Analysis: Galderma Group N"},{"type":"heading","level":3,"text":"Galderma Group N Connections"},{"type":"image","alt":"Network diagram: Galderma Group N AG"},{"type":"paragraph","text":"The map shows how Galderma Group N connects to ETFs, indices and other names. Each link is based on measured data and is not a recommendation."},{"type":"list","ordered":false,"items":[{"text":"Switzerland Country · domicile","links":[{"text":"Switzerland","href":"https://alysly.com/markets/countries/ch/"}]},{"text":"Health Care Sector · sector","links":[{"text":"Health Care","href":"https://alysly.com/markets/stocks/by-sector/health-care/"}]},{"text":"Novartis Stock · similar ETF exposure","links":[{"text":"Novartis","href":"https://alysly.com/markets/stocks/novartis-ag-reg/"}]}]},{"type":"paragraph","text":"View the full data network","href":"https://alysly.com/markets/network/"},{"type":"heading","level":3,"text":"What ETF Is Galderma Group N In?"},{"type":"paragraph","text":"Galderma Group N has very high ETF coverage and is held by 25 of the 104 ETFs we track, which together follow 10 indices. That puts the stock in more ETFs than 92.5% of the 4,341 stocks we track.","links":[{"text":"4,341 stocks we track","href":"https://alysly.com/markets/stocks/"}]},{"type":"paragraph","text":"Data note 2","href":"#dn-2"},{"type":"table","caption":"What ETF is Galderma Group N in","columns":["ETF","Index","Weight","per €1,000 in the ETF"],"rows":[[{"text":"SPFS","href":"https://alysly.com/markets/etfs/state-street-spdr-msci-world-health-care-ucits-etf/"},{"text":"MSCI World Health Care","href":"https://alysly.com/markets/indices/msci-world-health-care/"},"0.47%","€4.69"],[{"text":"XDWH","href":"https://alysly.com/markets/etfs/xtrackers-msci-world-health-care-ucits-etf-1c/"},{"text":"MSCI World Health Care","href":"https://alysly.com/markets/indices/msci-world-health-care/"},"0.47%","€4.66"],[{"text":"IMEA","href":"https://alysly.com/markets/etfs/ishares-core-msci-europe-ucits-etf-eur-acc/"},{"text":"MSCI Europe","href":"https://alysly.com/markets/indices/msci-europe/"},"0.31%","€3.10"],[{"text":"XMEU / XIEE","links":[{"text":"XMEU","href":"https://alysly.com/markets/etfs/xtrackers-msci-europe-ucits-etf-1c/"}]},{"text":"MSCI Europe","href":"https://alysly.com/markets/indices/msci-europe/"},"0.31%","€3.06"],[{"text":"SPYE","href":"https://alysly.com/markets/etfs/state-street-spdr-msci-europe-ucits-etf/"},{"text":"MSCI Europe","href":"https://alysly.com/markets/indices/msci-europe/"},"0.30%","€3.01"],[{"text":"XSX6 / XSX7","links":[{"text":"XSX6","href":"https://alysly.com/markets/etfs/xtrackers-stoxx-europe-600-ucits-etf-1c/"}]},{"text":"STOXX Europe 600","href":"https://alysly.com/markets/indices/stoxx-600/"},"0.29%","€2.91"],[{"text":"EXSA","href":"https://alysly.com/markets/etfs/ishares-stoxx-europe-600-ucits-etf-de/"},{"text":"STOXX Europe 600","href":"https://alysly.com/markets/indices/stoxx-600/"},"0.29%","€2.90"],[{"text":"X600 / XESU","links":[{"text":"X600","href":"https://alysly.com/markets/etfs/xtrackers-stoxx-europe-600-ii-ucits-etf-1c/"}]},{"text":"STOXX Europe 600","href":"https://alysly.com/markets/indices/stoxx-600/"},"0.29%","€2.90"],[{"text":"EXUS / EXU1","links":[{"text":"EXUS","href":"https://alysly.com/markets/etfs/xtrackers-msci-world-ex-usa-ucits-etf-1c/"}]},{"text":"MSCI World ex USA","href":"https://alysly.com/markets/indices/msci-world-ex-usa/"},"0.17%","€1.73"],[{"text":"XDEM","href":"https://alysly.com/markets/etfs/xtrackers-msci-world-momentum-ucits-etf-1c/"},{"text":"MSCI World Momentum","href":"https://alysly.com/markets/indices/msci-world-momentum/"},"0.15%","€1.49"],[{"text":"SPYI / SPSA","links":[{"text":"SPYI","href":"https://alysly.com/markets/etfs/state-street-spdr-msci-all-country-world-investable-market-ucits-etf-acc/"}]},{"text":"MSCI ACWI IMI","href":"https://alysly.com/markets/indices/msci-acwi-imi/"},"0.09%","€0.86"],[{"text":"XDEB","href":"https://alysly.com/markets/etfs/xtrackers-msci-world-minimum-volatility-ucits-etf-1c/"},{"text":"MSCI World Minimum Volatility","href":"https://alysly.com/markets/indices/msci-world-minimum-volatility/"},"0.05%","€0.55"],[{"text":"WIMI","href":"https://alysly.com/markets/etfs/xtrackers-msci-world-imi-ucits-etf-1c/"},{"text":"MSCI World IMI","href":"https://alysly.com/markets/indices/msci-world-imi/"},"0.05%","€0.52"],[{"text":"EUNL","href":"https://alysly.com/markets/etfs/ishares-core-msci-world-ucits-etf-usd-acc/"},{"text":"MSCI World","href":"https://alysly.com/markets/indices/msci-world/"},"0.05%","€0.50"],[{"text":"SWWD","href":"https://alysly.com/markets/etfs/state-street-spdr-msci-world-ucits-etf-dist/"},{"text":"MSCI World","href":"https://alysly.com/markets/indices/msci-world/"},"0.05%","€0.47"],[{"text":"SPPW","href":"https://alysly.com/markets/etfs/spdr-msci-world-ucits-etf/"},{"text":"MSCI World","href":"https://alysly.com/markets/indices/msci-world/"},"0.05%","€0.47"],[{"text":"XDWD / XDWL","links":[{"text":"XDWD","href":"https://alysly.com/markets/etfs/xtrackers-msci-world-ucits-etf-1c/"}]},{"text":"MSCI World","href":"https://alysly.com/markets/indices/msci-world/"},"0.05%","€0.46"],[{"text":"IUSQ","href":"https://alysly.com/markets/etfs/ishares-msci-acwi-ucits-etf-usd-acc/"},{"text":"MSCI ACWI","href":"https://alysly.com/markets/indices/msci-acwi/"},"0.04%","€0.40"],[{"text":"SPYY","href":"https://alysly.com/markets/etfs/state-street-spdr-msci-all-country-world-ucits-etf-acc/"},{"text":"MSCI ACWI","href":"https://alysly.com/markets/indices/msci-acwi/"},"0.04%","€0.40"]]},{"type":"paragraph","text":"Data note 3","href":"#dn-3"},{"type":"paragraph","text":"The last column shows how much of €1,000 in one of these funds goes to Galderma Group N, based on each fund's latest holdings list."},{"type":"paragraph","text":"US-listed ETFs holding Galderma Group N (weight per latest SEC filing): VXUS 0.09%. These funds are registered in the US; retail investors in the EU usually cannot buy them.","links":[{"text":"VXUS","href":"https://alysly.com/markets/etfs/us/vxus/"}]},{"type":"list","ordered":false,"items":[{"text":"Galderma Group N among the 4,341 stocks we track","href":"https://alysly.com/markets/stocks/etf-concentration/"},{"text":"Check the overlap of these 25 funds","href":"https://alysly.com/markets/etfs/overlap/"}]},{"type":"heading","level":3,"text":"Galderma Group N Weight in iShares STOXX Europe 600 (EXSA) Since 2024"},{"type":"image","alt":"Galderma Group N: weight in EXSA 0.04% → 0.29%"},{"type":"paragraph","text":"Jun 28, 2024 Oct 30, 2026"},{"type":"paragraph","text":"In iShares STOXX Europe 600 (EXSA), Galderma Group N had a weight of 0.04% on Jun 28, 2024 and 0.29% on Oct 30, 2026. The fund tracks the STOXX Europe 600. That is also the stock's highest weight in the period shown. The weight rises and falls with the stock's price performance relative to the other index members. It can also change when the index provider adjusts the index composition.","links":[{"text":"iShares STOXX Europe 600 (EXSA)","href":"https://alysly.com/markets/etfs/ishares-stoxx-europe-600-ucits-etf-de/"},{"text":"STOXX Europe 600","href":"https://alysly.com/markets/indices/stoxx-600/"}]},{"type":"paragraph","text":"Data note 4","href":"#dn-4"},{"type":"paragraph","text":"What's Inside Your ETF Portfolio and the ETF overlap check show how much Galderma Group N overlaps with the rest of a portfolio.","links":[{"text":"What's Inside Your ETF Portfolio","href":"https://alysly.com/tools/portfolio-xray/"},{"text":"ETF overlap check","href":"https://alysly.com/tools/etf-overlap/"}]},{"type":"heading","level":3,"text":"Stocks With ETF Exposure Similar to Galderma Group N"},{"type":"table","caption":"Stocks with ETF exposure similar to Galderma Group N","columns":["Stock","Shared ETFs","r","1 year","Annualized volatility","Net margin","Revenue growth"],"rows":[["Galderma Group N","–","–","–","–","–","–"],[{"text":"Genmab A/S","href":"https://alysly.com/markets/stocks/genmab/"},"24","–","+99.0%","40.3%","–","–"],[{"text":"Sandoz Group Ltd","href":"https://alysly.com/markets/stocks/sandoz-group-ltd/"},"24","–","–","–","–","–"],[{"text":"Swedish Orphan Biovitrum","href":"https://alysly.com/markets/stocks/swedish-orphan-biovitrum-ab/"},"24","–","–","–","–","–"],[{"text":"Demant A/S","href":"https://alysly.com/markets/stocks/demant/"},"23","–","–","–","–","–"],[{"text":"Haleon","href":"https://alysly.com/markets/stocks/haleon-plc/"},"23","–","-5.7%","24.5%","–","–"],[{"text":"Novartis","href":"https://alysly.com/markets/stocks/novartis-ag-reg/"},"25","–","–","–","–","–"],[{"text":"Alcon","href":"https://alysly.com/markets/stocks/alcon-inc/"},"23","–","-3.8%","27.5%","–","–"],[{"text":"Lonza Group","href":"https://alysly.com/markets/stocks/lonza-group-ag-reg/"},"23","–","–","–","–","–"]]},{"type":"paragraph","text":"These stocks reach a portfolio through largely the same funds as Galderma Group N. “Shared ETFs” counts the funds that hold both."},{"type":"paragraph","text":"Return and volatility are calculated from our daily closing prices in US dollars. Margin and growth come from each company's latest SEC annual filing. Because fiscal years do not end on the same date for every company, the underlying periods are not fully identical."},{"type":"paragraph","text":"Data note 5","href":"#dn-5"},{"type":"heading","level":2,"id":"refs","text":"Related Content: Galderma Group N"},{"type":"heading","level":3,"text":"Latest Investment Analysis: Stocks"},{"type":"list","ordered":false,"items":[{"text":"Oct 31, 2026 · Mixed Weekly Analysis: DAX Sets the Tone for the Week (+2.2%) · October 26–30, 2026","href":"https://alysly.com/analysis/weekly-analysis-dax-sets-tone-week-plus-2-2-percent-10312026/"},{"text":"Oct 24, 2026 · Risk-off Weekly Analysis: A Quiet Week, MSCI China -4.3% · October 19–23, 2026","href":"https://alysly.com/analysis/weekly-analysis-quiet-week-msci-china-minus-4-3-percent-10242026/"},{"text":"Oct 17, 2026 · Risk-off Weekly Analysis: S&P 500 Information Technology Weighs on the Week (-7.7%) · October 12–16, 2026","href":"https://alysly.com/analysis/weekly-analysis-sp-500-information-technology-weighs-week-10172026/"}]},{"type":"paragraph","text":"View all Investment Analysis","href":"https://alysly.com/analysis/"},{"type":"paragraph","text":"Updated Nov 2, 2026"},{"type":"heading","level":2,"id":"note-legend-h","text":"Data Notes"},{"type":"paragraph","text":"All calculations run automatically and are not investment advice."},{"type":"list","ordered":true,"items":[{"id":"dn-1","text":"Number of ETFs with available holdings data that hold the stock; the percentile compares all covered stocks against that same set."},{"id":"dn-2","text":"We count the funds we cover, not the market; the history covers the funds whose holdings reach back monthly."},{"id":"dn-3","text":"Holdings as of the fund's latest published holdings list; the as-of date is shown at the block."},{"id":"dn-4","text":"From the fund's published holdings lists at each quarter end, plus the latest date."},{"id":"dn-5","text":"Selected by how many of the funds we track hold both names, not by business model."}]},{"type":"paragraph","text":"Data and methodology: Alysly · Responsible for content: Alexander Bock","links":[{"text":"Alysly","href":"https://alysly.com/methodology/"},{"text":"Alexander Bock","href":"https://alysly.com/about/"}]},{"type":"paragraph","text":"View all data notes","href":"https://alysly.com/notes/"}],"structured_data":[{"@context":"https://schema.org","@graph":[{"@type":"Organization","@id":"https://alysly.com/#org","name":"Alysly","url":"https://alysly.com/","logo":{"@type":"ImageObject","url":"https://alysly.com/img/icon-512.png","width":512,"height":512},"description":"Data-driven insights, transparent analysis and powerful tools for long-term investors.","email":"mail@alysly.com","contactPoint":{"@type":"ContactPoint","contactType":"customer support","email":"mail@alysly.com","availableLanguage":["de","en"]},"address":{"@type":"PostalAddress","addressLocality":"Haltern am See","postalCode":"45721","addressCountry":"DE"},"founder":{"@id":"https://alysly.com/#founder"},"sameAs":["https://www.linkedin.com/company/alyslycom/","https://www.youtube.com/@alyslycom","https://x.com/alyslycom"],"publishingPrinciples":"https://alysly.com/methodology/"},{"@type":"Person","@id":"https://alysly.com/#founder","name":"Alexander Bock","jobTitle":"Founder and data analyst","url":"https://alysly.com/about/","sameAs":["https://www.linkedin.com/in/abxk/"]},{"@type":"WebSite","@id":"https://alysly.com/#site","url":"https://alysly.com/","name":"Alysly","alternateName":"Alysly Investment Analysis","inLanguage":"en-US","publisher":{"@id":"https://alysly.com/#org"},"potentialAction":{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https://alysly.com/markets/stocks/browse/?q={search_term_string}"},"query-input":"required name=search_term_string"}},{"@type":"WebPage","@id":"https://alysly.com/markets/stocks/galderma-group-ag/#webpage","url":"https://alysly.com/markets/stocks/galderma-group-ag/","name":"Galderma Group N AG – Alysly","description":"Galderma Group N AG (GALD). Health Care stock, Switzerland. Held in 25 ETFs (top 0.47% in SPFS). ISIN CH1335392721.","inLanguage":"en-US","isPartOf":{"@id":"https://alysly.com/#site"},"dateModified":"2026-11-02T00:00:00Z","publisher":{"@id":"https://alysly.com/#org"},"mainEntity":{"@id":"https://alysly.com/markets/stocks/galderma-group-ag/#entity"},"primaryImageOfPage":{"@type":"ImageObject","url":"https://alysly.com/og.png","width":1200,"height":630}}]},{"@context":"https://schema.org","@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1,"name":"Markets","item":"https://alysly.com/markets/"},{"@type":"ListItem","position":2,"name":"Stocks","item":"https://alysly.com/markets/stocks/"},{"@type":"ListItem","position":3,"name":"Galderma Group N AG"}]},{"@context":"https://schema.org","@type":"Corporation","@id":"https://alysly.com/markets/stocks/galderma-group-ag/#entity","name":"Galderma Group N AG","tickerSymbol":"GALD","url":"https://alysly.com/markets/stocks/galderma-group-ag/","mainEntityOfPage":"https://alysly.com/markets/stocks/galderma-group-ag/","description":"Galderma Group N AG (GALD). Health Care stock, Switzerland. Held in 25 ETFs (top 0.47% in SPFS). ISIN CH1335392721.","logo":"https://alysly.com/stock-logos/galderma-group-logo.webp","image":"https://alysly.com/stock-logos/galderma-group-logo.webp","identifier":[{"@type":"PropertyValue","propertyID":"TICKER","value":"GALD"},{"@type":"PropertyValue","propertyID":"ISIN","value":"CH1335392721"}],"address":{"@type":"PostalAddress","addressCountry":"CH"},"subjectOf":{"@type":"Dataset","name":"Galderma Group N AG — key figures","url":"https://alysly.com/markets/stocks/galderma-group-ag/","description":"Galderma Group N AG (GALD). Health Care stock, Switzerland. Held in 25 ETFs (top 0.47% in SPFS). ISIN CH1335392721.","inLanguage":"en-US","isAccessibleForFree":true,"creator":{"@id":"https://alysly.com/#org"},"publisher":{"@id":"https://alysly.com/#org"},"variableMeasured":[{"@type":"PropertyValue","name":"Held in ETFs","value":25},{"@type":"PropertyValue","name":"Highest ETF weight (%)","value":0.4691},{"@type":"PropertyValue","name":"Sector","value":"Health Care"}]}}],"notice":"© 2026 Alysly.com. Not investment advice. All data without guarantee. Financial information is analyzed and presented partly with AI assistance."}